ASGR1 and neoplasm: Glycoconjugation could be exploited in targeting the asialoglycoprotein receptor (ASGPR) since this strategy has displayed increased tumor accumulation and anticancer activity of the systems conjugated with sugar units recognized by ASGPR (D’Souza and Devarajan, 2015).